UNIVERSITY OF KENTUCKY
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 1865-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.uky.edu
Clinical Trials
85
Active:2
Completed:46
Trial Phases
6 Phases
Early Phase 1:4
Phase 1:15
Phase 2:5
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (64 trials with phase data)β’ Click on a phase to view related trials
Not Applicable
36 (56.3%)Phase 1
15 (23.4%)Phase 2
5 (7.8%)Early Phase 1
4 (6.3%)Phase 3
2 (3.1%)Phase 4
2 (3.1%)Recovery of Physical Function After Critical Illness In Older Adults
Not yet recruiting
- Conditions
- SepsisAcute Lung Injury(ALI)
- First Posted Date
- 2025-11-06
- Last Posted Date
- 2025-11-06
- Lead Sponsor
- University of Kentucky
- Target Recruit Count
- 150
- Registration Number
- NCT07225257
- Locations
- πΊπΈ
University of Kentucky, Lexington, Kentucky 40536, Lexington, Kentucky, United States
Kentucky Women's Justice Community Overdose Innovation Network - Phase II
Not Applicable
Not yet recruiting
- Conditions
- Overdose RiskOpioid Use DisorderStimulant Use Disorders
- First Posted Date
- 2025-09-18
- Last Posted Date
- 2025-11-12
- Lead Sponsor
- Michele Staton
- Target Recruit Count
- 300
- Registration Number
- NCT07179614
- Locations
- πΊπΈ
University of Kentucky, Lexington, Kentucky, United States
Training Induced Muscle-Adipose EV Communication
Not Applicable
Not yet recruiting
- Conditions
- Prediabetes
- First Posted Date
- 2025-08-06
- Last Posted Date
- 2025-08-06
- Lead Sponsor
- University of Kentucky
- Target Recruit Count
- 80
- Registration Number
- NCT07106450
Families Moving Together Curriculum
Not Applicable
Active, not recruiting
- Conditions
- Physical ActivitiesFamilies
- First Posted Date
- 2025-07-24
- Last Posted Date
- 2025-08-07
- Lead Sponsor
- Deirdre Dlugonski
- Target Recruit Count
- 58
- Registration Number
- NCT07084064
- Locations
- πΊπΈ
Wethington Building, Lexington, Kentucky, United States
Methamphetamine and Troriluzole
Early Phase 1
Recruiting
- Conditions
- Methamphetamine Use Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-05-25
- Last Posted Date
- 2025-09-03
- Lead Sponsor
- University of Kentucky
- Target Recruit Count
- 40
- Registration Number
- NCT06989853
- Locations
- πΊπΈ
Psychopharmacology of Addiction Laboratory, Lexington, Kentucky, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 17
- Next
News
University of Kentucky Researchers Explore Medical Cannabis for Late-Stage Dementia
University of Kentucky researchers are conducting the LiBBY Study to assess medical cannabis for managing agitation and discomfort in late-stage dementia patients.